Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.

van der Kroef M, van den Hoogen LL, Mertens JS, Blokland SLM, Haskett S, Devaprasad A, Carvalheiro T, Chouri E, Vazirpanah N, Cossu M, Wichers CGK, Silva-Cardoso SC, Affandi AJ, Bekker CPJ, Lopes AP, Hillen MR, Bonte-Mineur F, Kok MR, Beretta L, Rossato M, Mingueneau M, van Roon JAG, Radstake TRDJ.

Eur J Immunol. 2019 Aug 19. doi: 10.1002/eji.201948129. [Epub ahead of print]

PMID:
31424086
2.

S1PR5 is essential for human natural killer cell migration toward sphingosine-1 phosphate.

Drouillard A, Mathieu AL, Marçais A, Belot A, Viel S, Mingueneau M, Guckian K, Walzer T.

J Allergy Clin Immunol. 2018 Jun;141(6):2265-2268.e1. doi: 10.1016/j.jaci.2017.11.022. Epub 2017 Dec 14. No abstract available.

PMID:
29248494
3.

Role of the IL-12/IL-35 balance in patients with Sjögren syndrome.

Fogel O, Rivière E, Seror R, Nocturne G, Boudaoud S, Ly B, Gottenberg JE, Le Guern V, Dubost JJ, Nititham J, Taylor KE, Chanson P, Dieudé P, Criswell LA, Jagla B, Thai A, Mingueneau M, Mariette X, Miceli-Richard C.

J Allergy Clin Immunol. 2018 Jul;142(1):258-268.e5. doi: 10.1016/j.jaci.2017.07.041. Epub 2017 Sep 12.

PMID:
28916184
4.

RNA-Seq and CyTOF immuno-profiling of regenerating lacrimal glands identifies a novel subset of cells expressing muscle-related proteins.

Hawley D, Ding J, Thotakura S, Haskett S, Aluri H, Kublin C, Michel A, Clapisson L, Mingueneau M, Zoukhri D.

PLoS One. 2017 Jun 29;12(6):e0179385. doi: 10.1371/journal.pone.0179385. eCollection 2017.

5.

The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.

Szymaniak AD, Mi R, McCarthy SE, Gower AC, Reynolds TL, Mingueneau M, Kukuruzinska M, Varelas X.

Elife. 2017 May 11;6. pii: e23499. doi: 10.7554/eLife.23499.

6.

Identification of Novel CD4+ T Cell Subsets in the Target Tissue of Sjögren's Syndrome and Their Differential Regulation by the Lymphotoxin/LIGHT Signaling Axis.

Haskett S, Ding J, Zhang W, Thai A, Cullen P, Xu S, Petersen B, Kuznetsov G, Jandreski L, Hamann S, Reynolds TL, Allaire N, Zheng TS, Mingueneau M.

J Immunol. 2016 Nov 15;197(10):3806-3819. Epub 2016 Oct 7.

7.

Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.

Zhao L, Nocturne G, Haskett S, Boudaoud S, Lazure T, Le Pajolec C, Mariette X, Mingueneau M, Banerjee D.

Rheumatology (Oxford). 2017 Feb;56(2):303-312. doi: 10.1093/rheumatology/kew360. Epub 2016 Nov 1.

PMID:
27803305
8.

BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.

Ding J, Zhang W, Haskett S, Pellerin A, Xu S, Petersen B, Jandreski L, Hamann S, Reynolds TL, Zheng TS, Mingueneau M.

Clin Immunol. 2016 Aug;169:69-79. doi: 10.1016/j.clim.2016.06.007. Epub 2016 Jun 25.

PMID:
27352977
9.

Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation.

Mingueneau M, Boudaoud S, Haskett S, Reynolds TL, Nocturne G, Norton E, Zhang X, Constant M, Park D, Wang W, Lazure T, Le Pajolec C, Ergun A, Mariette X.

J Allergy Clin Immunol. 2016 Jun;137(6):1809-1821.e12. doi: 10.1016/j.jaci.2016.01.024. Epub 2016 Apr 1.

PMID:
27045581
10.

A multidisciplinary guided practical on type I diabetes engaging students in inquiry-based learning.

Mingueneau M, Chaix A, Scotti N, Chaix J, Reynders A, Hammond C, Thimonier J.

Adv Physiol Educ. 2015 Dec;39(4):383-91. doi: 10.1152/advan.00045.2015.

11.

Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3.

Yan D, Farache J, Mingueneau M, Mathis D, Benoist C.

Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14942-7. doi: 10.1073/pnas.1520393112. Epub 2015 Nov 16. Erratum in: Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E256. Mingueneau, Michael [added].

12.

Hands-on experiments on glycemia regulation and type 1 diabetes.

Mingueneau M, Chaix A, Scotti N, Chaix J, Reynders A, Hammond C, Thimonier J.

Adv Physiol Educ. 2015 Sep;39(3):232-9. doi: 10.1152/advan.00047.2015. Review.

13.

Single-cell mass cytometry of TCR signaling: amplification of small initial differences results in low ERK activation in NOD mice.

Mingueneau M, Krishnaswamy S, Spitzer MH, Bendall SC, Stone EL, Hedrick SM, Pe'er D, Mathis D, Nolan GP, Benoist C.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16466-71. doi: 10.1073/pnas.1419337111. Epub 2014 Oct 31.

14.

Systems biology. Conditional density-based analysis of T cell signaling in single-cell data.

Krishnaswamy S, Spitzer MH, Mingueneau M, Bendall SC, Litvin O, Stone E, Pe'er D, Nolan GP.

Science. 2014 Nov 28;346(6213):1250689. doi: 10.1126/science.1250689. Epub 2014 Oct 23.

15.

The transcriptional landscape of αβ T cell differentiation.

Mingueneau M, Kreslavsky T, Gray D, Heng T, Cruse R, Ericson J, Bendall S, Spitzer MH, Nolan GP, Kobayashi K, von Boehmer H, Mathis D, Benoist C; Immunological Genome Consortium, Best AJ, Knell J, Goldrath A, Joic V, Koller D, Shay T, Regev A, Cohen N, Brennan P, Brenner M, Kim F, Nageswara Rao T, Wagers A, Heng T, Ericson J, Rothamel K, Ortiz-Lopez A, Mathis D, Benoist C, Bezman NA, Sun JC, Min-Oo G, Kim CC, Lanier LL, Miller J, Brown B, Merad M, Gautier EL, Jakubzick C, Randolph GJ, Monach P, Blair DA, Dustin ML, Shinton SA, Hardy RR, Laidlaw D, Collins J, Gazit R, Rossi DJ, Malhotra N, Sylvia K, Kang J, Kreslavsky T, Fletcher A, Elpek K, Bellemare-Pelletier A, Malhotra D, Turley S.

Nat Immunol. 2013 Jun;14(6):619-32. doi: 10.1038/ni.2590. Epub 2013 May 5.

16.

Thymic negative selection is functional in NOD mice.

Mingueneau M, Jiang W, Feuerer M, Mathis D, Benoist C.

J Exp Med. 2012 Mar 12;209(3):623-37. doi: 10.1084/jem.20112593. Epub 2012 Feb 13.

17.

LAT signaling pathology: an "autoimmune" condition without T cell self-reactivity.

Roncagalli R, Mingueneau M, Grégoire C, Malissen M, Malissen B.

Trends Immunol. 2010 Jul;31(7):253-9. doi: 10.1016/j.it.2010.05.001. Epub 2010 Jun 9. Review.

PMID:
20542732
18.

Tonic ubiquitylation controls T-cell receptor:CD3 complex expression during T-cell development.

Wang H, Holst J, Woo SR, Guy C, Bettini M, Wang Y, Shafer A, Naramura M, Mingueneau M, Dragone LL, Hayes SM, Malissen B, Band H, Vignali DA.

EMBO J. 2010 Apr 7;29(7):1285-98. doi: 10.1038/emboj.2010.10. Epub 2010 Feb 11.

19.

Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomes.

Roncagalli R, Mingueneau M, Grégoire C, Langlet C, Malissen B, Malissen M.

Semin Immunopathol. 2010 Jun;32(2):117-25. doi: 10.1007/s00281-009-0195-y. Epub 2010 Jan 28. Review.

PMID:
20107804
20.

Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor.

Mingueneau M, Roncagalli R, Grégoire C, Kissenpfennig A, Miazek A, Archambaud C, Wang Y, Perrin P, Bertosio E, Sansoni A, Richelme S, Locksley RM, Aguado E, Malissen M, Malissen B.

Immunity. 2009 Aug 21;31(2):197-208. doi: 10.1016/j.immuni.2009.05.013. Epub 2009 Aug 13.

21.

STAT6 deletion converts the Th2 inflammatory pathology afflicting Lat(Y136F) mice into a lymphoproliferative disorder involving Th1 and CD8 effector T cells.

Archambaud C, Sansoni A, Mingueneau M, Devilard E, Delsol G, Malissen B, Malissen M.

J Immunol. 2009 Mar 1;182(5):2680-9. doi: 10.4049/jimmunol.0803257.

22.

The proline-rich sequence of CD3epsilon controls T cell antigen receptor expression on and signaling potency in preselection CD4+CD8+ thymocytes.

Mingueneau M, Sansoni A, Grégoire C, Roncagalli R, Aguado E, Weiss A, Malissen M, Malissen B.

Nat Immunol. 2008 May;9(5):522-32. doi: 10.1038/ni.1608. Epub 2008 Apr 13.

PMID:
18408722
23.

Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells.

Wang Y, Kissenpfennig A, Mingueneau M, Richelme S, Perrin P, Chevrier S, Genton C, Lucas B, DiSanto JP, Acha-Orbea H, Malissen B, Malissen M.

J Immunol. 2008 Feb 1;180(3):1565-75.

24.

Th2 lymphoproliferative disorders resulting from defective LAT signalosomes.

Malissen B, Wang Y, Mingueneau M, Malissen M.

Novartis Found Symp. 2007;281:93-100; discussion 100-2, 208-9. Review.

PMID:
17534068
25.

Multiplicity and plasticity of natural killer cell signaling pathways.

Chiesa S, Mingueneau M, Fuseri N, Malissen B, Raulet DH, Malissen M, Vivier E, Tomasello E.

Blood. 2006 Mar 15;107(6):2364-72. Epub 2005 Nov 15.

Supplemental Content

Loading ...
Support Center